Want to join the conversation?
Chemicals company $EMN reported 4Q15 net earnings of $124MM or $0.83 per diluted share, up 675% from $16MM or $0.11 per diluted share YoverY, helped by lower cost of sales. As-reported EPS was $1.59 per diluted share versus $1.64 per diluted share in 4Q14. Sales fell 5.3% to $2.2Bil in the quarter, hurt by lower sales in most segments.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.